Skip to content

Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways

A Pragmatic Randomized Controlled Trial of Patient-Centered Integrated Clinical Pathways Based Versus Usual Care in an Academic Center: National Guard Health Affairs Western Region Experience

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01561885
Acronym
CHAMP-Path
Enrollment
341
Registered
2012-03-23
Start date
2012-03-31
Completion date
2016-03-31
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Asthma, Community Acquired Pneumonia, Heart Failure, Venous Thromboembolism

Keywords

Clinical Pathways, Length of Stay, Patient-Centered Care, Pragmatic Randomized Controlled Trial

Brief summary

The aim of this study is to determine if by providing a collaborative, integrated pathway-based healthcare compared to the usual healthcare, whether or not this would be superior in reducing the length of hospital stay across five high frequency /high risk medical diagnoses: Acute Venous Thromboembolism, Acute Kidney Injury, Community Acquired Pneumonia, Adult Left Ventricular Heart Failure, and Asthma.

Detailed description

This study is a pragmatic randomized controlled trial. To date, there is a scarcity of randomized controlled trials looking at pathway-based, patient-centered healthcare versus usual care in several high-risk or high volume diagnoses that account for the vast majority of hospitalizations in medical settings. In this study, the pathway care intervention is a collaborative effort that involves healthcare professionals from multiple departments, including pharmacists, health educators, nurses, social workers, nutritionists, and quality management. For patients allocated to the usual care, these healthcare professionals will deliver standardized care when consulted. For pathway care patients, this collaborative healthcare will be default.

Interventions

OTHERPathway-Based Care

Patients who are randomly allocated to Pathway Care will be treated by the Pathway Clinical Teaching Unit as well as other collaborative healthcare professionals (pharmacists, nurses, health educators, nutritionists, and social workers). The Pathway Care physicians will have access to the Clinical Care Plan on the QuadraMed, which is a detailed, organized, day-to-day treatment plan that includes pre-set orders and medications. Physicians for the patients on Usual Care will not have access to this information, and the collaborative healthcare will only be provided upon consultation.

Sponsors

Majed Aljeraisy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Inclusion Criteria (Overall Criteria): * One principle diagnosis * Hemodynamic Stability 2. Inclusion Criteria (Specific to each Diagnosis): Acute Venous Thromboembolism: * New onset / in-patient Acute Kidney Injury: * Patients with increased serum creatinine of more than 50% from baseline Community Acquired Pneumonia: * Age limit Adult Left Ventricular Heart Failure: * Age limit Asthma * Acute exacerbation of Asthma 3.

Exclusion criteria

(Overall Criteria): * Intensive Care Unit (ICU) patients * Pregnancy 4.

Design outcomes

Primary

MeasureTime frame
Decrease in length of hospital stay by two daysDuring hospitalization period of 7 to 10 days

Secondary

MeasureTime frameDescription
30-Day RehospitalizationAfter discharge up to 30 daysTo determine the effect of the pathway-based care versus usual care on 30-day rehospitalization rates for the same diagnosis
Determinants of the Length of StayUpon admission until discharge
Pathway Care Specific Clinical OutcomesUpon admission until dischargeFor pathway care, there are specific targeted outcomes that ought to be met.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026